Pregnancy involves plenty of tests, scans and appointments, especially during the first few months. While some tests track the mother’s health or the baby’s growth, others look for signs that may indicate a higher chance of certain genetic or chromosomal conditions.
This is where chromosomal screening comes in. The terminology can sound complicated, but the basic purpose is quite straightforward. These tests help doctors estimate whether a pregnancy has a higher or lower chance of certain chromosomal abnormalities. They do not, by themselves, confirm that a baby has a genetic condition.
Understanding that difference is important. A screening report can sometimes cause unnecessary worry when a higher-risk result is interpreted as a diagnosis. Knowing what the test measures, when it is done and what happens after the report can make the process easier to navigate.
What Are Chromosomal Abnormalities?
Chromosomes carry the genetic information that helps determine how the body develops and functions. Most people have 46 chromosomes, arranged in 23 pairs. Sometimes, a baby may have an extra chromosome or a missing chromosome. These changes are known as chromosomal abnormalities.
Some of the more commonly discussed conditions include Down syndrome, which is associated with an extra copy of chromosome 21, Edwards syndrome, associated with trisomy 18, and Patau syndrome, associated with trisomy 13.
Several factors, including maternal age, can influence the likelihood of certain chromosomal conditions. However, chromosomal screening is not limited to pregnancies considered high risk. Current guidance recommends discussing and offering prenatal genetic screening and diagnostic options to pregnant patients regardless of age or baseline risk.
What Does Chromosomal Screening Actually Do?
Chromosomal screening estimates the likelihood that a pregnancy may be affected by a particular chromosomal condition.
That sounds similar to diagnosis, but the two are quite different.
A screening test answers a question such as, “Is the chance higher or lower than expected?” A diagnostic test is designed to determine whether the condition is actually present.
For instance, a report may classify a pregnancy as having a higher chance of Down syndrome. This does not mean the baby definitely has Down syndrome. Likewise, a low-risk result does not guarantee that the baby has no chromosomal or other developmental condition.
This distinction is particularly important when reading prenatal test reports. The result needs to be interpreted alongside the mother’s age, gestational age, ultrasound findings and other relevant clinical information.
What Is the Double Marker Test?
The double marker test is a first-trimester maternal blood screening test. It measures two substances in the mother’s blood: free beta-hCG and pregnancy-associated plasma protein A, or PAPP-A.
Free beta-hCG is a hormone produced by the placenta, while PAPP-A is a protein associated with placental development. Their levels are assessed as part of an overall risk calculation rather than being treated as a standalone diagnosis.
The test is performed during early pregnancy. The reference article places the blood collection window between 8 and 14 weeks, with 11 to 13 weeks described as the preferred period. The treating doctor should decide the exact timing because gestational age is important when interpreting the results.
The test itself is simple. It involves collecting a blood sample from the mother, so there is no procedure involving the uterus or the baby.
How Is the Double Marker Test Used With an NT Scan?
The blood test is often considered along with a nuchal translucency, or NT, ultrasound.
During an NT scan, the sonographer measures the fluid-filled space at the back of the baby’s neck. This measurement is part of the overall first-trimester assessment.
The blood markers and ultrasound findings provide different pieces of information. When considered together with factors such as maternal age and gestational age, they can help calculate the likelihood of certain chromosomal abnormalities. The Hinduja Hospital reference also explains that the blood test and NT scan are used together to place the pregnancy into a risk category.
It is therefore better to view these assessments as pieces of the same clinical picture rather than as isolated tests.
What Do the Results Mean?
A chromosomal screening report provides a risk estimate rather than a simple “yes” or “no”.
A low-risk or screen-negative result means the calculated likelihood of the screened condition is lower. It is reassuring, but it cannot completely rule out a chromosomal abnormality.
A higher-risk or screen-positive result means the calculated likelihood is above the screening threshold used by the laboratory or screening programme. It does not confirm that the baby has the condition.
This is one area where people can easily misread a report. A ratio such as 1 in 1,000 and another such as 1 in 100 represent different levels of estimated risk, but neither number should be interpreted without knowing how the laboratory calculated the result.
The double marker test also has limitations. False-positive and false-negative results can occur, so it should not be treated as a diagnostic test.
What Happens After a Higher-Risk Result?
A higher-risk screening result does not automatically mean that something is wrong with the baby. Instead, it usually means that the doctor may recommend discussing further testing.
Depending on the circumstances, this could include another form of prenatal screening or a diagnostic test. Cell-free DNA screening, commonly called NIPT, is one screening option. It analyses small fragments of placental DNA found in the mother’s bloodstream and can screen for common chromosomal conditions, including trisomy 21, trisomy 18 and trisomy 13. It can be performed from around 10 weeks of pregnancy.
However, NIPT is also a screening test. A positive result needs confirmation through diagnostic testing before a definite conclusion is made.
Diagnostic procedures such as chorionic villus sampling, or CVS, and amniocentesis involve collecting fetal or placental material for laboratory analysis. These tests can provide diagnostic information, but they differ from routine blood screening and come with their own considerations.
The right next step depends on the individual pregnancy. A doctor may consider the screening result alongside ultrasound findings, medical history and other factors before recommending further testing.
How Is NIPT Different From First-Trimester Screening?
Both approaches can provide information about the likelihood of chromosomal abnormalities, but they work differently.
First-trimester screening can combine maternal blood markers with an ultrasound assessment. NIPT uses cell-free DNA from the placenta circulating in the mother’s blood.
ACOG describes cell-free DNA screening as a highly sensitive and specific method for screening for common fetal aneuploidies. Even so, it remains a screening test rather than a diagnostic test.
This does not necessarily mean that one test is automatically suitable for every pregnancy. The choice should consider what conditions are being screened for, the stage of pregnancy, previous test results, ultrasound findings and the mother’s preferences.
Why Routine Ultrasound Remains Important
Chromosomal screening does not replace routine pregnancy scans.
Ultrasound can provide information about the baby’s growth and physical development and may identify structural abnormalities that chromosomal screening may not detect.
This is why prenatal care usually involves more than one type of assessment. A blood screening test can provide one kind of information, while ultrasound can provide another. Looking at both can give the obstetrician a more complete picture of the pregnancy.
Does Every Pregnant Woman Need Chromosomal Screening?
No single testing pathway applies identically to every pregnancy.
Prenatal genetic screening is a choice, and patients can discuss the available options with their obstetrician. ACOG notes that genetic testing is not compulsory and that the decision can depend on personal preferences, risk factors and what someone wants to know during pregnancy.
Some people want as much information as possible about potential genetic conditions. Others may feel that additional testing would create more anxiety than reassurance. Neither response is unusual.
Genetic counselling can be useful when the options feel overwhelming. A genetic counsellor can explain what a particular test screens for, its limitations, and what different results could mean.
Questions Worth Asking Before the Test
Before undergoing chromosomal screening, it can help to ask the doctor:
- Which chromosomal conditions does this test screen for?
- When should the test be performed?
- Is it a screening test or a diagnostic test?
- Will the result be combined with an ultrasound?
- How will the risk be expressed in the report?
- What happens if the result is screen positive?
- Would another screening or diagnostic test be appropriate?
- Are there any factors in the pregnancy that could affect interpretation?
These questions can make a complicated-looking report easier to understand.
Conclusion
Chromosomal screening during pregnancy is primarily about understanding risk, not predicting a baby’s health with absolute certainty.
Tests such as the double marker test examine specific markers in the mother’s blood and may be assessed alongside an NT scan and other pregnancy details. Other options, including cell-free DNA screening, offer different ways to assess the likelihood of common chromosomal conditions.
The most important point is to remember that screening is not a diagnosis. A higher-risk result does not automatically mean that a baby has a chromosomal abnormality, while a low-risk result cannot rule out every condition.
If a screening report raises questions, discussing the findings with an obstetrician or qualified genetic counsellor is the safest way to understand what they mean and whether further testing is appropriate. Prenatal screening is about giving parents and doctors useful information so that healthcare decisions can be made with a clearer understanding of the pregnancy.